NASDAQ: SGHT · Industrial Applications and Services · 7 alerts · CIK 1531177
Share price
$10.59Close, Nov 16
Market cap
$589M
Shares outstanding
55.58MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Sight Sciences, Inc. filings on SEC EDGAR ↗
Sight Sciences, Inc. reported total assets of $104.9 million as of September 30, 2026, a decrease from $115.3 million at the end of 2025, primarily driven by a reduction in cash and cash equivalents. The company continues to focus on its Interventional Glaucoma and Dry Eye products while implementing cost-reduction plans to manage operating expenses and net losses.
Sight Sciences reported record third-quarter 2026 revenue of $24.9 million, a 25% increase year-over-year, driven by significant growth in its Interventional Dry Eye segment. The company improved its net loss to $6.8 million and raised its full-year 2026 revenue guidance to a range of $99.1 million to $101.1 million.
“We delivered another strong quarter with 25% total revenue growth, record IDE revenue, continued IG revenue growth, and a significant reduction in cash burn. These results demonstrate increasing adoption of our technologies, disciplined execution across our organization, and our growing impact on patients with glaucoma and dry eye disease.”
Sight Sciences EVP, Operations & R&D Brenton Taylor Sells $26.5K of Stock
Brenton Taylor, EVP, Operations & R&D, sold 2,988 shares of Sight Sciences, Inc. at $8.85 a share, worth $26.5K in total on Oct 2, 2026. Shares held after the trade: 261,990 (-1.1%).
Sight Sciences COO Alison Bauerlein Sells $224K of Stock
Alison Bauerlein, COO, sold 25,260 shares of Sight Sciences, Inc. at $8.85 a share, worth $224K in total on Oct 2, 2026. Shares held after the trade: 639,449 (-3.8%).
Sight Sciences CFO James Rodberg Sells $63.8K of Stock
James Rodberg, CFO, sold 7,208 shares of Sight Sciences, Inc. at $8.85 a share, worth $63.8K in total on Oct 2, 2026. Shares held after the trade: 216,829 (-3.2%).
Sight Sciences CTO David Badawi Sells $70.6K of Stock
David Badawi, CTO, sold 7,797 shares of Sight Sciences, Inc. at $9.05 a share, worth $70.6K in total on Oct 1, 2026. Shares held after the trade: 1,975,075 (-0.4%).
Sight Sciences President and CEO Paul Badawi Sells $268K of Stock
Paul Badawi, President and CEO, sold 29,653 shares of Sight Sciences, Inc. at $9.05 a share, worth $268K in total on Oct 1, 2026. Shares held after the trade: 6,092,819 (-0.5%).